JP2559035B2 - 細胞生長調節因子 - Google Patents

細胞生長調節因子

Info

Publication number
JP2559035B2
JP2559035B2 JP61301853A JP30185386A JP2559035B2 JP 2559035 B2 JP2559035 B2 JP 2559035B2 JP 61301853 A JP61301853 A JP 61301853A JP 30185386 A JP30185386 A JP 30185386A JP 2559035 B2 JP2559035 B2 JP 2559035B2
Authority
JP
Japan
Prior art keywords
polypeptide
cells
cell growth
oncostatin
growth regulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61301853A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62236498A (ja
Inventor
エム ゼアリング ジヨイス
シヨーヤブ モハメド
マーカード ハンス
ビー ハンソン マーシア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of JPS62236498A publication Critical patent/JPS62236498A/ja
Application granted granted Critical
Publication of JP2559035B2 publication Critical patent/JP2559035B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP61301853A 1985-12-20 1986-12-19 細胞生長調節因子 Expired - Lifetime JP2559035B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US811235 1985-12-20
US93528386A 1986-11-26 1986-11-26
US935283 1986-11-26

Publications (2)

Publication Number Publication Date
JPS62236498A JPS62236498A (ja) 1987-10-16
JP2559035B2 true JP2559035B2 (ja) 1996-11-27

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61301853A Expired - Lifetime JP2559035B2 (ja) 1985-12-20 1986-12-19 細胞生長調節因子

Country Status (29)

Country Link
JP (1) JP2559035B2 (de)
KR (1) KR920005920B1 (de)
CN (1) CN1017626B (de)
AT (1) AT400444B (de)
AU (2) AU601168B2 (de)
BE (1) BE905957A (de)
CA (1) CA1340296C (de)
CH (1) CH675727A5 (de)
CY (1) CY1608A (de)
DE (2) DE3645095C2 (de)
DK (1) DK174094B1 (de)
ES (1) ES2003180A6 (de)
FI (1) FI91484C (de)
FR (1) FR2597108B1 (de)
GB (1) GB2185485B (de)
GR (1) GR862936B (de)
HK (1) HK65691A (de)
HU (1) HU210694B (de)
IE (1) IE59415B1 (de)
IL (1) IL81017A (de)
IT (1) IT1213428B (de)
LU (1) LU86718A1 (de)
NL (1) NL8603209A (de)
NO (1) NO174556C (de)
NZ (1) NZ218634A (de)
OA (1) OA08494A (de)
PT (1) PT83986B (de)
SE (1) SE505059C2 (de)
SG (1) SG60891G (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
FR2597108A1 (fr) 1987-10-16
FR2597108B1 (fr) 1991-02-15
CH675727A5 (de) 1990-10-31
GR862936B (en) 1987-10-28
AT400444B (de) 1995-12-27
DE3645095C2 (de) 1993-11-18
DE3643428A1 (de) 1987-09-24
SE8605459L (sv) 1987-06-21
IL81017A0 (en) 1987-03-31
CN1017626B (zh) 1992-07-29
DK174094B1 (da) 2002-06-10
CA1340296C (en) 1998-12-29
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
DK615386A (da) 1987-06-21
NL8603209A (nl) 1987-07-16
AU639048B2 (en) 1993-07-15
HU210694B (en) 1995-06-28
NZ218634A (en) 1991-06-25
GB8629997D0 (en) 1987-01-28
ATA340686A (de) 1995-05-15
PT83986A (en) 1987-01-01
CY1608A (en) 1992-04-03
JPS62236498A (ja) 1987-10-16
IL81017A (en) 1993-01-14
DK615386D0 (da) 1986-12-18
SE505059C2 (sv) 1997-06-16
IE863345L (en) 1987-06-20
LU86718A1 (fr) 1988-07-14
GB2185485B (en) 1990-07-04
OA08494A (fr) 1988-07-29
FI91484C (fi) 1994-07-11
BE905957A (fr) 1987-06-17
SG60891G (en) 1991-08-23
KR870005645A (ko) 1987-07-06
NO174556B (no) 1994-02-14
SE8605459D0 (sv) 1986-12-18
IT8622787A0 (it) 1986-12-19
IT1213428B (it) 1989-12-20
PT83986B (pt) 1989-07-31
HK65691A (en) 1991-08-23
NO174556C (no) 1994-05-25
KR920005920B1 (ko) 1992-07-24
NO865178L (no) 1987-06-22
AU601168B2 (en) 1990-09-06
FI91484B (fi) 1994-03-31
IE59415B1 (en) 1994-02-23
AU6660886A (en) 1987-06-25
AU6776590A (en) 1991-03-14
CN86108955A (zh) 1987-12-02
ES2003180A6 (es) 1988-10-16
HUT43103A (en) 1987-09-28
GB2185485A (en) 1987-07-22
NO865178D0 (no) 1986-12-19
DE3643428C2 (de) 1990-08-23

Similar Documents

Publication Publication Date Title
Pober et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
EP0692536B1 (de) Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
JP4099119B2 (ja) 表面複合リンホトキシン
Vogel et al. Correction of defective macrophage differentiation in C3H/HeJ mice by an interferon-like molecule.
US5213970A (en) Method for obtaining soluble antitumor factor
US4613459A (en) Lymphocyte growth factor
JP2559035B2 (ja) 細胞生長調節因子
US5112948A (en) Methods and compositions for inducing monocyte cytotoxicity
EP0341273B1 (de) Biologische materialien, deren herstellung und verwendung in der therapie
US4722998A (en) Method of producing lymphocyte growth factors
US5434247A (en) Peptides for inducing monocyte cytotoxicity in diagnostics
EP0487613B1 (de) Megakaryocytopoietischer faktor
US5071956A (en) Protein with vascular activity derived from monocytes and its analogues, a process for its extraction and their uses for therapeutic purposes and for the preparation of antibodies
EP0234545A2 (de) Gereinigter humaner Angiogenfaktor, Verfahren zu seiner Herstellung und pharmazeutische Präparate
JP2000505643A (ja) レクチン様性質を有する化合物およびその生物学的応用
RU2076151C1 (ru) Способ получения фактора некроза опухоли, человеческий фактор некроза опухоли
WO1989010133A1 (en) Stem cell inhibitors
JPH03277284A (ja) 遺伝子及びその製造法
Turck et al. Diverse responses of human fibroblasts to a highly purified fibroblast-activating factor from the U937 line of human monocytes.
JPS6130526A (ja) リンパ球増殖因子
WO1992007875A1 (en) Cytolytic factor associated with effector cell plasma membranes

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term